Gastroenterologist Dr. Avlin Imaeda and ABC News medical correspondent Dr. Darien Sutton said the common gastrointestinal side effects of GLP-1 medications are significant [1, 2].
Understanding these reactions is critical as these drugs see widespread adoption for weight loss and diabetes management. Because the medications fundamentally alter how the digestive system functions, patients must distinguish between expected side effects and severe medical complications.
During a segment on the ABC News Live YouTube channel, the experts said gastrointestinal issues are the most frequent complaints for those using GLP-1 drugs [1]. These medications slow the rate at which the stomach empties, which can lead to a variety of digestive disturbances [1, 2].
Dr. Imaeda said supplements should be used carefully while taking these medications [1]. The discussion emphasized that certain supplements should be avoided to prevent exacerbating the side effects caused by the drugs [1, 2].
While these medications provide significant benefits for some, they carry risks that can be difficult to diagnose. Reports indicate that in some cases, the side effects of medications like Mounjaro can mimic the symptoms of bowel perforation [3].
Additionally, the rise of these pharmaceutical options has shifted the landscape of obesity treatment in the U.S. Reports show that as GLP-1 drugs have increased in popularity, the rates of bariatric surgery have plummeted across the country [4].
Medical professionals said patients should maintain open communication with their providers regarding any new digestive symptoms. This ensures that standard side effects are not mistaken for more critical surgical emergencies [1, 3].
“Gastrointestinal side effects are the most common with GLP-1 drugs.”
The shift from surgical interventions to GLP-1 medications represents a fundamental change in obesity treatment. However, the prevalence of gastrointestinal side effects creates a diagnostic challenge for clinicians, as common drug reactions may mask life-threatening conditions like bowel perforation, necessitating more rigorous patient monitoring.
